Potentiation by thyroxine of interferon-gamma-induced antiviral state requires PKA and PKC activities. [electronic resource]
- The American journal of physiology Oct 1996
- C1256-61 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
0002-9513
10.1152/ajpcell.1996.271.4.C1256 doi
Animals Calmodulin--pharmacology Carbazoles Cyclic AMP--physiology Cyclic AMP-Dependent Protein Kinase Type II Cyclic AMP-Dependent Protein Kinases--antagonists & inhibitors Dose-Response Relationship, Drug Drug Synergism Enzyme Inhibitors--pharmacology Estrenes--pharmacology HeLa Cells Humans Indoles--pharmacology Interferon-gamma--administration & dosage L Cells Mice Protein Kinase C--antagonists & inhibitors Pyrroles--pharmacology Pyrrolidinones--pharmacology Rhabdoviridae Infections--physiopathology Staurosporine--analogs & derivatives Sulfonamides--pharmacology Tetradecanoylphorbol Acetate--pharmacology Thyroxine--administration & dosage Time Factors Vesicular stomatitis Indiana virus Viral Interference--drug effects